FDA to Lift Mandate on Prescription Drug Pedigrees
15th Nov 2006, 05:24 GMT
RFID is being studied and recommended to not only comply with e-pedigree, but for so-called track and trace efficiencies as well. However, there remain issues to overcome.
FDA to Lift Mandate on Prescription Drug Pedigrees related news:
- FDA Urges Caution on Flu Drug — WSJ.com: What's News US
- FDA Suggests New Tamiflu Warning — WSJ.com: What's News US
- FDA Extends Novartis Drug Review — WSJ.com: What's News Europe
- FDA Decision on Novartis Drug Is Delayed — WSJ.com: What's News Europe
- FDA Orders Caution Over the use of Tamiflu — NPR Topics: Nation
- FDA Seeks Boost in Drug Company Fees — Financial News News from StratCenter.com
- Drug Safety Reform and Risk Management Plans - A Test Case? Senior FDA Policymakers and Experts to Answer Urgent Questions at Windhover's FDA/CMS Summit Dec 4-5, Washington, DC — RedOrbit News - Health
- Déjà vu for Medicare prescription drug plan — The Daily News: Opinion
- Dendreon Asks FDA to OK Prostate Drug — Government/ Industry Regulation News from StratCenter.com
- Medicare drug coverage: the vital facts — Daily Star Front Page
Latest news from eWEEK Technology News:
- Samsung Says DRAM Demand for Q1 2007 'Very Strong'
- Apple Hires IBM's Rosenberg as General Counsel
- Lycos Seeks Rebirth as 'Virtual Living Room'
- Cutting Out the Middleman
- Appro Delivers Supercomputing Clusters to Lawrence Livermore Labs
- Jack in the Box Forgoes Contactless Trial, Opts for Immediate Rollout
- IBM to Join Citigroup Bid for Chinese Bank Stake
- Cognos, Panorama Launch New BI Platforms for SAP
- Critical Flaw Haunts D-Link Wi-Fi Driver
- Juniper Updates Access Control Software